Meridian Bioscience Gets FDA Re-authorization Of EUA For Revogene SARS-CoV-2 Molecular Assay

RTTNews | 1125日前
Meridian Bioscience Gets FDA Re-authorization Of EUA For Revogene SARS-CoV-2 Molecular Assay

(RTTNews) - Diagnostic testing provider Meridian Bioscience, Inc. (VIVO) announced Friday that it received re-authorization of its Emergency Use Authorization (EUA) for the Revogene SARS-COV-2 molecular assay from the U.S. Food and Drug Administration (FDA).

Meridian expects to begin shipping this product before the end of its fiscal fourth quarter, ending September 30, 2022.

On November 10, 2021, Meridian announced the Revogene SARS-CoV-2 assay was granted authorization by the FDA. Subsequent to that, it was determined that the original design of the assay would not detect the Omicron variant.

Over the last few months in consultation with the FDA, Meridian completed additional clinical studies and the FDA has now re-authorized the EUA.

For More Such Health News, visit rttnews.com

read more
Hong Kong Shares Poised To End Two-Day Slide

Hong Kong Shares Poised To End Two-Day Slide

The Hong Kong stock market has finished lower in consecutive trading days, tumbling almost 630 points or 2.5 percent along the way. The Hang Seng Index now rests just above the 25,200-point plateau although it may find traction on Thursday.
RTTNews | 2分前
China Stock Market May Stop The Bleeding On Thursday

China Stock Market May Stop The Bleeding On Thursday

The China stock market has finished lower in two straight sessions, retreating more than 80 points or 2.1 percent along the way. The Shanghai Composite Index now sits just above the 3,800-point plateau although it's due for support on Thursday.
RTTNews | 17分前
Taiwan Stock Market May Extend Winning Streak

Taiwan Stock Market May Extend Winning Streak

The Taiwan stock market has tracked higher in three straight sessions, gathering more than 750 points or 3.1 percent along the way. The Taiwan Stock Exchange now rests just beneath the 24,520-point plateau and it may add to its winnings again on Thursday.
RTTNews | 47分前
Singapore Stock Market May Extend Wednesday's Gains

Singapore Stock Market May Extend Wednesday's Gains

The Singapore stock market bounced higher again on Wednesday, one day after snapping the five-day winning streak in which it had climbed almost 70 points or 1.6 percent. The Straits Times Index now sits just above the 4,245-point plateau and it may pick up steam on Thursday.
RTTNews | 1時17分前
Malaysia Bourse May Add To Its Winnings On Thursday

Malaysia Bourse May Add To Its Winnings On Thursday

The Malaysia stock market rebounded on Wednesday, one day after ending the three-day winning streak in which it had collected almost 15 points or 0.9 percent. The Kuala Lumpur Composite Index now sits just above the 1,585-point plateau and it's expected to open in the green again on Thursday.
RTTNews | 1時47分前
Higher Open Called For Japan Stock Market

Higher Open Called For Japan Stock Market

The Japan stock market bounced higher again on Wednesday, one session after ending the two-day winning streak in which it had advanced almost 200 points or 0.5 percent. The Nikkei 225 now rests just above the 42,520-point plateau and it's expected to open to the upside again on Thursday.
RTTNews | 2時2分前
KOSPI May Reclaim 3,200-Point Level

KOSPI May Reclaim 3,200-Point Level

The South Korea stock market bounced higher again on Wednesday, one day after ending the three-day winning streak in which it had improved almost 80 points or 2.6 percent. The KOSPI now sits just shy of the 3,190-point plateau and it may tick higher again on Thursday.
RTTNews | 2時17分前
Korea Interest Rate Decision Due On Thursday

Korea Interest Rate Decision Due On Thursday

The Bank of Korea will wrap up its monetary policy meeting this morning and then announce its decision on interest rates, highlighting a light day for Asia-Pacific economic activity. The BoK is expected to keep its benchmark lending rate unchanged at 2.50 percent.
RTTNews | 3時17分前